Related Experiment Videos

Intravenous miconazole therapy for experimental keratomycosis in rabbits

Sabouraudia
|February 1, 1985
PubMed

Insights

Intravenous miconazole treatment significantly reduced Candida albicans fungal keratitis intensity in rabbits. Treated rabbits showed improved clinical scores and negative cultures, unlike controls.

Area of Science:

  • Ophthalmology
  • Mycology
  • Pharmacology

Background:

  • Fungal keratitis, particularly Candida albicans infections, poses a significant threat to vision.
  • Effective treatment options for fungal keratitis are crucial for preventing vision loss.

Purpose of the Study:

  • To evaluate the efficacy of intravenous miconazole in treating experimental fungal keratitis caused by Candida albicans in rabbits.

Main Methods:

  • A controlled study involving 20 rabbits with experimentally induced Candida albicans fungal keratitis.
  • Ten rabbits received intravenous miconazole (90 mg daily for 3 weeks), while 10 served as untreated controls.
  • Clinical scoring, corneal scrapings for fungal culture, and histopathological examination were performed.

Main Results:

  • Intravenous miconazole significantly reduced the intensity of fungal keratitis compared to the control group.
  • Corneal cultures were negative by day 18 in the miconazole-treated group, whereas four controls remained positive on day 21.
  • Histopathological analysis revealed substantially lower inflammatory changes in the eyes of treated rabbits.

Conclusions:

  • Intravenous miconazole demonstrates significant efficacy in treating experimental Candida albicans fungal keratitis in rabbits.
  • This treatment approach offers a promising therapeutic strategy for fungal eye infections.

Related Concept Videos